Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines
- 1 January 1994
- Vol. 12 (3) , 195-199
- https://doi.org/10.1016/0264-410x(94)90194-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Oral immunisation against typhoid fever in Indonesia with Ty21a vaccineThe Lancet, 1991
- Salmonella typhi Infections in the United States, 1975-1984: Increasing Role of Foreign TravelClinical Infectious Diseases, 1989
- Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid feverVaccine, 1988
- PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVERThe Lancet, 1987
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987
- Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid feverEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in FinlandThe Journal of Infectious Diseases, 1977
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- A SEVEN-YEAR FIELD TRIAL OF TWO TYPHOID VACCINES IN GUYANAThe Lancet, 1967
- THE INFLUENCE OF DOSAGE AND ROUTE OF INJECTION ON THE ANTIBODY RESPONSE OF HUMAN SUBJECTS TO THE SPECIFIC CARBOHYDRATE OF THE TYPE VIII PNEUMOCOCCUS 1Journal of Clinical Investigation, 1935